Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 019174
Company: GLAXOSMITHKLINE
Company: GLAXOSMITHKLINE
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
TRANDATE HCT | HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE | 25MG;100MG | TABLET;ORAL | Discontinued | None | No | No |
TRANDATE HCT | HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE | 25MG;200MG | TABLET;ORAL | Discontinued | None | No | No |
TRANDATE HCT | HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE | 25MG;300MG | TABLET;ORAL | Discontinued | None | No | No |
TRANDATE HCT | HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE | 25MG;400MG | TABLET;ORAL | Discontinued | None | No | No |